Indeed, in a TCGA pan-cancer analysis, uveal melanoma had one of the strongest associations between patient outcomes and CDKN1B mRNA expression, with higher expression observed in patients with higher rates of metastasis [53]. This evidence concerns the gene CDKN1B and uveal melanoma.